PSIL Among Its Peers
End-of-day Nov 13, 2026 · 1 ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −0.8% | −6.4% | −25.6% | +12.0% | +12.2% | +55.2% | −77.9% | −77.6% |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$118 of every $1,000 in PSIL is Definium
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics | 11.84% |
| 2 | CMPS | Compass Pathways | 10.56% |
| 3 | HELP | Helus Pharma | 7.89% |
| 4 | LLY | ELI Lilly & | 6.55% |
| 5 | RLMD | Relmada Therapeutics | 6.27% |
| 6 | NBIX | Neurocrine Biosciences | 5.94% |
| 7 | ABBV | Abbvie | 5.84% |
| 8 | SPTX | Seaport Therapeutics | 5.16% |
| 9 | ANRO | Alto Neuroscience | 5.15% |
| 10 | INDV | Supernus | 4.88% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | DFTXDefinium Therapeutics | Healthcare | 11.84% | $1,183.94 | 153K | $5.1M |
| 2 | CMPSCompass Pathways | Healthcare | 10.56% | $1,056.43 | 494K | $4.5M |
| 3 | HELPHelus Pharma | Healthcare | 7.89% | $789.14 | 380K | $3.4M |
| 4 | LLYELI Lilly | Healthcare | 6.55% | $654.65 | 1,960 | $2.8M |
| 5 | RLMDRelmada Therapeutics | Healthcare | 6.27% | $626.89 | 643K | $2.7M |
| 6 | NBIXNeurocrine Biosciences | Healthcare | 5.94% | $593.53 | 15K | $2.5M |
| 7 | ABBVAbbvie | Healthcare | 5.84% | $584.41 | 8,471 | $2.5M |
| 8 | SPTXSeaport Therapeutics | Healthcare | 5.16% | $515.67 | 109K | $2.2M |
| 9 | ANROAlto Neuroscience | Healthcare | 5.15% | $515.45 | 72K | $2.2M |
| 10 | INDVSupernus | Healthcare | 4.88% | $488.08 | 71K | $2.1M |
| 11 | JNJJohnson & Johnson | Healthcare | 4.81% | $481.08 | 7,242 | $2.1M |
| 12 | GHRSGH Research | Healthcare | 4.42% | $442.05 | 102K | $1.9M |
| 13 | NRXPNRX Pharmaceuticals | Healthcare | 3.96% | $395.74 | 741K | $1.7M |
| 14 | STIMNeuronetics | Healthcare | 3.51% | $351.35 | 1.0M | $1.5M |
| 15 | DRUGBright Minds Biosciences | Healthcare | 2.57% | $256.90 | 48K | $1.1M |
PSIL has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| PSIL | 0.31 | 0.47 | 39.6% | −30.4% | 1.20 | $128 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $1.68 |
| Sep 22, 2025 | Sep 29, 2025 | $0.0201 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0119 |
| Mar 21, 2025 | Mar 28, 2025 | $0.16 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0548 |
| Sep 23, 2024 | Sep 30, 2024 | $0.11 |
| Sep 25, 2023 | Sep 29, 2023 | $0.34 |
| Sep 26, 2022 | Sep 30, 2022 | $5.41 |